DPP-4 Inhibitors: Cost-effectiveness / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 955-958, 2012.
Article
in Zh
| WPRIM
| ID: wpr-430352
Responsible library:
WPRO
ABSTRACT
China is the country with the biggest diabetic population in the world.Diabetes has become a heavy financial burden for diabetic patients,families,and society.This article briefly described pharmacoeconomic concepts and analysis methods,and systemically reviewed literatures in health economic data of DPP-4 inhibitors,in the hope of providing a new perspective for clinicians,researchers,and health care policy makers.
Full text:
1
Index:
WPRIM
Type of study:
Health_economic_evaluation
Language:
Zh
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2012
Type:
Article